IRCT20130418013058N16招募中2 期
Evaluation of the effectiveness of crocin as a supplement in patients with refractory focal epilepsy in a randomized double-blind clinical trial
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16 years 至 70 years（—）
- 性别
- All
入选标准
- •Patients with refractory focal epilepsy based on the examination of a specialist doctor
- •Patients should be taking at least one fixed-dose regimen of one to three anti-epileptic drugs
- •The number of refractory focal epilepsy attacks in should be at least 5 attacks at 3 months before the study
- •Written consent to participate
- •No heart, kidney and liver diseases and not having blood diseases problems and coagulation diseases
排除标准
- •Female patients were excluded if they were pregnant, lactating, or of childbearing age and not using approved methods of contraception.
- •Patients were excluded if they had previously received crocin or participated in any other research trial within the previous 2 months.
- •Patients were also excluded from the study if they had a history of substance abuse such as alcohol or drugs during the sample collection period.
- •Any medical conditions that may endanger the patient's health or compromise the patient's ability to participate in the trial will be excluded from the study.
- •Have a history of severe anaphylaxis or serious blood dyscrasia
- •Any other significant clinical condition, or recent chronic use of non-AED medications that may interfere with drug absorption, distribution, metabolism, or excretion.
- •Regular treatment with one of the following drugs that affect the CNS. such as neuroleptics , monoamine oxidase (MAO) inhibitors, barbiturates (except when taken as concomitant anticonvulsant therapy), or narcotic analgesics within 4 weeks prior to enrollment.
- •Suffering from psychiatric disorders or behavioral disorders, bipolar disorder, schizophrenia or suicidal tendencies or any other mental disorder.
- •Life-limiting conditions that cause the patient to be unable to complete the course of treatment and need another drug
- •Allergy to saffron
- •Suffering from any other serious diseases such as heart, liver and kidney diseases during treatment
研究者
相似试验
招募中
2 期
Evaluation of the effect of crocin in the treatment of cystoid macular edema secondary to retinitis pigmentosaIRCT20201219049753N2Mashhad University of Medical Sciences20
招募中
3 期
Therapeutic effect of crocin along with chemotherapy regimens in breast cancerBreast cancer.Malignant neoplasm of breast of unspecified siteC50.9IRCT20131017015044N3Mashhad University of Medical Sciences100
招募中
2 期
Effect of crocin on ocular complications of Behcet's diseaseBehcet's diseaseIRCT20130418013058N12Mashhad University of Medical Sciences40
已完成
2 期
Effect of crocin supplementation in treatment of methadone maintenance treatment patientsAddiction.Mental and behavioural disorders due to multiple drug use and use of other psychoactive substancesIRCT20170420033551N4Kashan University of Medical Sciences60
招募中
3 期
Evaluation of the therapeutic effect of crocin along with standard regimes in colorectal cancercolorectal cancer.Malignant neoplasm of rectosigmoid junctionIRCT20131017015044N2Mashhad University of Medical Sciences100